Hopewell Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Hopewell Therapeutics's estimated annual revenue is currently $1.6M per year.
- Hopewell Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Hopewell Therapeutics has 21 Employees.
- Hopewell Therapeutics grew their employee count by -25% last year.
Hopewell Therapeutics's People
Name | Title | Email/Phone |
---|
Hopewell Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Hopewell Therapeutics?
Hopewell is a privately held biotechnology company based in Woburn, Massachusetts.It was founded by Dr. Qiaobing Xu, Professor of Biomedical Engineering at Tufts University and a world-renowned leader in the application of material science engineering to biomedicine, with a focus on advancing the field of genomic medicine with leading-edge lipid nanoparticle (LNP) delivery technology. The company established operations with a seed financing round in January 2022.Leveraging an extensive intellectual property portfolio licensed from Tufts and augmented at Hopewell, the company specializes in synthesizing and developing targeted, efficient, and safe LNPs supporting diverse cargoes to address unmet medical needs through its differentiated ATLAS platform. Hopewell’s LNP platform serves as an engine for both internal pipeline programs and external collaborations. With a fully operational lab and an experienced team, Hopewell has established broad R&D capabilities spanning lipid synthesis, mRNA cargo development, and LNP development.
keywords:N/AN/A
Total Funding
21
Number of Employees
$1.6M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.3M | 21 | -12% | N/A |
#2 | $5.3M | 21 | 0% | N/A |
#3 | $2.1M | 21 | 0% | N/A |
#4 | N/A | 21 | 11% | N/A |
#5 | $3.4M | 23 | -12% | N/A |